Xponential Fitness, Inc. (XPOF) Financial Statements
Xponential Fitness, Inc. (XPOF) reported trailing twelve-month revenue of $288.5M (down 9.0% year on year) and net income of -$42.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$8.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
XPOFXponential Fitness, Inc.Follow XPOF — free
—
Price chart with a free account
- Market cap
- 206.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 155.1 | 243.2 | 317.9 | 320.3 | 314.9 | 288.5 | |
| Gross profit | 113.8 | 196.7 | 241.6 | 239.1 | 250.1 | 237.6 | |
| Operating income | -30.8 | 13.3 | 34.9 | -53.6 | 19.8 | 17.9 | |
| Pre-tax income | -50.7 | 1.6 | -5.4 | -99.0 | -52.3 | -57.4 | |
| Income tax | 0.8 | 0.5 | 1.0 | -0.3 | 1.3 | 0.6 | |
| Net income | -18.8 | 1.2 | -4.0 | -67.7 | -38.7 | -42.6 | |
| Diluted EPS ($) | -2.85 | -0.88 | -0.52 | -2.27 | -1.47 | -1.25 | |
| Diluted shares (mn) | 22.4 | 25.3 | 39.7 | 32.0 | 34.8 | — |
USD millions · SEC XBRL
Xponential Fitness, Inc. — questions
- What is Xponential Fitness, Inc.'s revenue?
- $288.5M over the twelve months to 2026-06-30, down 9.0% year on year, from its 10-Q and 10-K filings.
- What is Xponential Fitness, Inc.'s net income?
- -$42.6M over the twelve months to 2026-06-30.
- What is Xponential Fitness, Inc.'s free cash flow?
- -$8.1M over the twelve months to 2026-06-30.
- What are Xponential Fitness, Inc.'s diluted earnings per share?
- $-1.25 over the twelve months to 2026-06-30.
Every figure on this page comes from Xponential Fitness, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.